Clinical Trial Update: FOLFOX/FOLFIRI Containing Levofolinic Acid (Zuoyu ®) in the Treatment of Unresectable or Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update for a FOLFOX/FOLFIRI regimen containing Levofolinic Acid (Zuoyu) in unresectable or metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Zuoyu (Levofolinic acid-containing regimen (FOLFOX/FOLFIRI with Zuoyu))

Snippet

Sponsor: China Medical University, China | Conditions: Unresectable or Metastatic Colorectal Cancer | Phase 2 | Status: UNKNOWN